Congress classified Marijuana as a Schedule One drug in the 1970 Controlled Substance Act. This Act secernd that Marijuana has a luxuriously potential for ab practice, no checkup subroutine, and it is not safe for use under medical supervision. Schedule One drugs argon the or so restrictive in the US Controlled Substance Act. Drugs like Clonitazene, Hydroxypethidine, and Morpheridine ar among the classified Schedule One series of drugs that can be found within Section 812 of the Schedules of Controlled Substances. Legalizing Marijuana has been a issuance of high interest in the United States for centuries, but it was until the mid-seventies that many places in the United States began to abolish state laws and opposite local regulations that banned the possession and sale of the drug (ProCon). accord to a 2010 Gallop Poll, 50% of Americans approve the legal use of Marijuana, although 46% do not and should remain illegal (Gallop Poll, 2010). The sort of Americans most likely to oppose are those age 65 and older, conservatives, and Republicans.
More Americans and medical professionals argue that legalizing medical Marijuana is a medical necessity and can be beneficial for several reasons.
Some of the reasons cited by former US Surgeon General, Jocelyn Elders, MD. in the Providence Journal were, evidence is enkindle that Marijuana can relieve certain types of pain, nausea, vomiting and former(a) symptoms caused by such illnesses as multiple sclerosis, cancer and support (Providence Journal, 2004). ProCons Medical Marijuana website shows that California was the first state that legalized the use of medical Marijuana in 1996. Since then 16 states and DC have enacted laws to legalize medical Marijuana. As of work on 8, 2012, there are 18 other states with pending economy to legalize the use of medical Marijuana (ProCon, 2012).
Marijuana as Medication
Medical Marijuana has been around for...If you want to get a full essay, order it on our website: Orderessay
If you want to get a full essay, wisit our page: write my essay .
No comments:
Post a Comment